Anne Samuel
Stock Analyst at JP Morgan
(3.41)
# 796
Out of 4,814 analysts
64
Total ratings
56.1%
Success rate
0.81%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Maintains: Neutral | $44 → $36 | $30.27 | +18.93% | 5 | Mar 20, 2025 | |
| VEEV Veeva Systems | Maintains: Neutral | $218 → $249 | $220.66 | +12.84% | 6 | Mar 20, 2025 | |
| EVH Evolent Health | Maintains: Overweight | $13 → $12 | $8.97 | +33.78% | 12 | Mar 10, 2025 | |
| IQV IQVIA Holdings | Maintains: Overweight | $240 → $232 | $143.91 | +61.21% | 6 | Feb 18, 2025 | |
| PGNY Progyny | Maintains: Neutral | $17 → $23 | $21.44 | +7.28% | 7 | Jan 28, 2025 | |
| DOCS Doximity | Maintains: Neutral | $30 → $48 | $53.20 | -9.77% | 5 | Nov 21, 2024 | |
| PHR Phreesia | Maintains: Overweight | $27 → $28 | $23.94 | +16.96% | 2 | Sep 9, 2024 | |
| PINC Premier | Maintains: Neutral | $21 → $19 | $19.45 | -2.31% | 4 | Sep 9, 2024 | |
| CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $18.77 | +11.88% | 3 | Sep 9, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $13 | $3.85 | +237.66% | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $36.44 | -25.91% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $2.53 | +98.02% | 1 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $86 → $108 | $84.52 | +27.78% | 8 | Apr 2, 2024 |
Omnicell
Mar 20, 2025
Maintains: Neutral
Price Target: $44 → $36
Current: $30.27
Upside: +18.93%
Veeva Systems
Mar 20, 2025
Maintains: Neutral
Price Target: $218 → $249
Current: $220.66
Upside: +12.84%
Evolent Health
Mar 10, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $8.97
Upside: +33.78%
IQVIA Holdings
Feb 18, 2025
Maintains: Overweight
Price Target: $240 → $232
Current: $143.91
Upside: +61.21%
Progyny
Jan 28, 2025
Maintains: Neutral
Price Target: $17 → $23
Current: $21.44
Upside: +7.28%
Doximity
Nov 21, 2024
Maintains: Neutral
Price Target: $30 → $48
Current: $53.20
Upside: -9.77%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $23.94
Upside: +16.96%
Premier
Sep 9, 2024
Maintains: Neutral
Price Target: $21 → $19
Current: $19.45
Upside: -2.31%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $18.77
Upside: +11.88%
Health Catalyst
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $3.85
Upside: +237.66%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $36.44
Upside: -25.91%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $2.53
Upside: +98.02%
Apr 2, 2024
Maintains: Overweight
Price Target: $86 → $108
Current: $84.52
Upside: +27.78%